Guanghui Energy expects Q1–Q3 net profit to rise 166.83% to 176.71%

上海证券报··CN·Read original
3▲7 ▼0Impact / 5
Summary · why it matters

Guanghui Energy expects net profit attributable to shareholders of the listed company for the first three quarters of 2026 to be between 2.70 billion yuan and 2.80 billion yuan, up 166.83% to 176.71% year on year. On the same day, several listed companies disclosed earnings forecasts for the first three quarters. Dongyue Silicone Materials expects net profit of 547 million yuan to 567 million yuan, up 19,050% to 19,750% year on year. Ben Chuan Intelligent expects net profit of 96 million yuan to 144 million yuan, up 190.24% to 335.36%. Amlogic expects net profit of 1.26 billion yuan to 1.31 billion yuan, up 80.58% to 87.74%. Dinglong shares expects net profit of 840 million yuan to 860 million yuan, up 61.72% to 65.57%. Yonghe shares expects net profit of 760 million yuan to 860 million yuan, up 61.96% to 83.27%. In company news, Xiongshu Technology is planning to acquire no more than 80% equity in Shenzhen Xinyuan New Materials by cash, with the overall valuation of 100% equity of the target company tentatively set at no more than 800 million yuan. Lianjian Technology plans to acquire equity in Zhejiang Huazhou Intelligent Equipment by cash of no more than 325 million yuan and obtain 51.10% equity through capital increase. The Phase III clinical trial of RAY1225 injection, a Class 1 innovative peptide drug independently developed by Zhongshan Rui Chuang, a holding subsidiary of Zhongsheng Pharmaceutical, in overweight or obese participants has obtained top-line analysis data and met the primary endpoint. In buybacks, Andeli plans to repurchase no less than 120 million yuan and no more than 180 million yuan of company shares, and Huaming Equipment plans to repurchase no less than 150 million yuan and no more than 250 million yuan, both for employee stock ownership plans or equity incentives. On the capital side, trading public information on October 8 showed that Zhongshi Technology received net institutional seat buying of 332 million yuan, accounting for 9.93% of total turnover. OGAWA received net institutional seat buying of 98.4992 million yuan, accounting for 12.62% of total turnover.

Impact on assets 13

Others▲
Hubei Dinglong Chemical
300054
▲ PositiveCapitalrelevance

Dinglong shares expects Q1-Q3 net profit up 61.72%-65.57% year on year, a positive earnings forecast.

Guangdong Xiongsu Technology Group Co Ltd
300599
± MixedCapitalrelevance

Xiongshu Technology plans a cash acquisition of up to 80% equity in Shenzhen Xinyuan New Materials at a valuation up to 800 million yuan; impact on the acquirer is unclear.